Pursuant to Regulation 30 read with Part A of Schedule III and Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform that the Board of Directors of the Company at its meeting held today i.e. May 25, 2026, has inter alia approved the following: 1. Audited Financial Results of the Company for the Quarter and Year ended as on March 31, 2026. Financial Results were duly reviewed by the Audit Committee and thereafter approved by the Board of Directors of the Company. \r\n\r\nThe above Financial Results are enclosed along with a declaration on Auditor's Report with unmodified opinion.\r\n2. Reappointment of Dr. Himalyani Gupta (DIN:00607140) as Non-Executive Independent Director of the Company for the second term of 5 (five) consecutive years w.e.f May 12, 2027. The Board reappointed Dr. Himalyani Gupta on the recommendations of the Nomination and Remuneration Committee and subject to the approval of the members of the Company.\r\n